68 related articles for article (PubMed ID: 20097467)
1. Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study.
Griesinger G; Berndt H; Schultz L; Depenbusch M; Schultze-Mosgau A
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):190-4. PubMed ID: 20097467
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
[TBL] [Abstract][Full Text] [Related]
3. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
Griesinger G; von Otte S; Schroer A; Ludwig AK; Diedrich K; Al-Hasani S; Schultze-Mosgau A
Hum Reprod; 2007 May; 22(5):1348-52. PubMed ID: 17303632
[TBL] [Abstract][Full Text] [Related]
4. Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study.
Griesinger G; Berndt H; Schultz L; Schultze-Mosgau A; Diedrich K; von Otte S
Reprod Biomed Online; 2011 Feb; 22(2):133-9. PubMed ID: 21227753
[TBL] [Abstract][Full Text] [Related]
5. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
6. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
7. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support.
Imbar T; Kol S; Lossos F; Bdolah Y; Hurwitz A; Haimov-Kochman R
Hum Reprod; 2012 Mar; 27(3):753-9. PubMed ID: 22252086
[TBL] [Abstract][Full Text] [Related]
8. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndrome.
Herrero L; Pareja S; Losada C; Cobo AC; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2011 Mar; 95(3):1137-40. PubMed ID: 21047635
[TBL] [Abstract][Full Text] [Related]
9. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
Gera PS; Tatpati LL; Allemand MC; Wentworth MA; Coddington CC
Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
11. GnRH agonist administration after embryo transfer, in long protocol stimulated cycles, prevents ovarian hyperstimulation syndrome. A report of five cases.
Nikolettos N; Asimakopoulos B; Simopoulou M; al-Hasani S
In Vivo; 2003; 17(6):655-8. PubMed ID: 14758735
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of oocyte cryopreservation: a meta-analysis.
Oktay K; Cil AP; Bang H
Fertil Steril; 2006 Jul; 86(1):70-80. PubMed ID: 16818031
[TBL] [Abstract][Full Text] [Related]
13. Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective study.
Lin YH; Huang MZ; Hwang JL; Chen HJ; Hsieh BC; Huang LW; Tzeng CR; Seow KM
J Assist Reprod Genet; 2013 Jun; 30(6):753-9. PubMed ID: 23606010
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction.
Cerrillo M; Rodríguez S; Mayoral M; Pacheco A; Martínez-Salazar J; Garcia-Velasco JA
Fertil Steril; 2009 Apr; 91(4 Suppl):1526-8. PubMed ID: 18990367
[TBL] [Abstract][Full Text] [Related]
15. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study.
Chen YH; Xu XH; Wang Q; Zhang SD; Jiang LL; Zhang CL; Ge ZJ
J Assist Reprod Genet; 2015 Oct; 32(10):1459-67. PubMed ID: 26384107
[TBL] [Abstract][Full Text] [Related]
16. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes.
Chian RC; Huang JY; Gilbert L; Son WY; Holzer H; Cui SJ; Buckett WM; Tulandi T; Tan SL
Fertil Steril; 2009 Jun; 91(6):2391-8. PubMed ID: 18579139
[TBL] [Abstract][Full Text] [Related]
17. Larger oocyte cohorts maximize fresh IVF cycle birth rates and availability of surplus high-quality blastocysts for cryopreservation.
Connell MT; Richter KS; Devine K; Hill MJ; DeCherney AH; Doyle JO; Tucker MJ; Levy MJ
Reprod Biomed Online; 2019 May; 38(5):711-723. PubMed ID: 30922557
[TBL] [Abstract][Full Text] [Related]
18. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome.
Zech J; Brandao A; Zech M; Lugger K; Neururer S; Ulmer H; Ruttmann-Ulmer E
Reprod Biol; 2018 Mar; 18(1):46-52. PubMed ID: 29279182
[TBL] [Abstract][Full Text] [Related]
19. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles.
Hill MJ; Miller KA; Frattarelli JL
Fertil Steril; 2010 Feb; 93(2):416-22. PubMed ID: 19171338
[TBL] [Abstract][Full Text] [Related]
20. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
Lee JR; Choi YS; Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH
Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
